Pharmaceuticals, Biotechnology and Life Sciences
-Eligible patients in Wales will soon have access to ORKAMBI® (lumacaftor/ivacaftor) and SYMKEVI® (tezacaftor/ivacaftor), expanded access to KALYDECO® (ivacaftor) under…
DUBLIN–(BUSINESS WIRE)–The “Dry Eye Medication Global Market Report 2020” report has been added to ResearchAndMarkets.com’s offering. Major players in the…
Rubraca® (rucaparib) offers a new monotherapy maintenance treatment option for eligible women with relapsed, platinum-sensitive ovarian cancer, who harbor either…
LONDON–(BUSINESS WIRE)–#AgenaBioscience–The global blood group typing market is poised to grow by USD 1.36 billion during 2019-2023, progressing at a…
BOSTON–(BUSINESS WIRE)–PureTech Health plc (LSE: PRTC) (“PureTech”), a clinical-stage biotechnology company dedicated to discovering, developing and commercializing highly differentiated medicines…
VALENCIA, Calif. & MELBOURNE, Australia–(BUSINESS WIRE)–AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned…
HONG KONG–(BUSINESS WIRE)–Cook Medical announced today that Jean-Marc Creissel has been named vice president and director of Asia-Pacific. In his…
BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that it has submitted an arbitration demand to the American Arbitration Association…
SALT LAKE CITY–(BUSINESS WIRE)–PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today reported…
NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulators for aesthetic and therapeutic indications,…